Xilio Therapeutics Ownership | Who Owns Xilio Therapeutics?
Xilio Therapeutics Ownership Summary
Xilio Therapeutics is owned by 46.69% institutional investors, 40.93% insiders, and 12.38% retail investors. Bain capital life sciences investors is the largest institutional shareholder, holding 13.56% of XLO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.68% of its assets in Xilio Therapeutics shares.
XLO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Xilio Therapeutics | 46.69% | 40.93% | 12.38% |
| Sector | Healthcare Stocks | 47.31% | 8.01% | 44.69% |
| Industry | Biotech Stocks | 45.43% | 7.81% | 46.75% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bain capital life sciences investors | 3.79M | 13.56% | $3.59M |
| Rock springs capital management lp | 3.00M | 10.76% | $2.85M |
| Rivervest venture management | 1.44M | 5.16% | $1.37M |
| Fmr | 1.40M | 5.00% | $1.32M |
| Morgan stanley | 1.11M | 3.99% | $1.05M |
| Vanguard group | 902.53K | 3.23% | $855.15K |
| Renaissance | 295.00K | 1.06% | $279.51K |
| Balyasny asset management | 272.49K | 0.98% | $258.18K |
| Fil | 218.71K | 0.78% | $207.22K |
| Geode capital management | 182.85K | 0.66% | $173.29K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Rivervest venture management | 1.44M | 20.01% | $1.37M |
| Bain capital life sciences investors | 3.79M | 0.39% | $3.59M |
| Rock springs capital management lp | 3.00M | 0.09% | $2.85M |
| Sevenbridge financial group | 41.00K | 0.01% | $37.18K |
| Dunhill financial | 10.27K | 0.01% | $9.73K |
| Pinnacle financial group, llc / il | 10.00K | 0.00% | $9.47K |
| Xtx topco | 33.29K | 0.00% | $31.54K |
| Bridgeway capital management | 71.08K | 0.00% | $67.35K |
| Avantax planning partners | 25.00K | 0.00% | $23.69K |
| Renaissance | 295.00K | 0.00% | $279.51K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rock springs capital management lp | 3.00M | 0.09% | 1.56M |
| Bain capital life sciences investors | 3.79M | 0.39% | 980.04K |
| Morgan stanley | 1.11M | 0.00% | 890.84K |
| Geode capital management | 182.85K | - | 98.03K |
| Renaissance | 295.00K | 0.00% | 45.55K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Atlas venture life science advisors | - | - | -992.91K |
| Fmr | 1.40M | 0.00% | -511.82K |
| Balyasny asset management | 272.49K | 0.00% | -66.06K |
| Millennium management | 12.21K | - | -57.99K |
| Pfg investments | - | - | -30.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Raymond james & associates | 38.83K | - | 38.83K | $36.79K |
| Xtx topco | 33.29K | 0.00% | 33.29K | $31.54K |
| Avantax planning partners | 25.00K | 0.00% | 25.00K | $23.69K |
| Two sigma securities | 13.27K | 0.00% | 13.27K | $12.57K |
| Pinnacle financial group, llc / il | 10.00K | 0.00% | 10.00K | $9.47K |
Sold Out
| Holder | Change |
|---|---|
| Qube research | -4.00 |
| Wells fargo & company/mn | -108.00 |
| Royal bank of canada | -533.00 |
| Adar1 capital management | -1.50K |
| Summit trail advisors | -16.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 30 | - | 13,033,702 | 18.53% | 46 | 2.93% | 16 | 45.45% | 5 | - |
| Mar 31, 2024 | 30 | -6.25% | 10,996,048 | -26.45% | 39 | 1.35% | 11 | -8.33% | 5 | 25.00% |
| Dec 31, 2023 | 32 | 3.23% | 14,951,160 | -5.73% | 54 | 1.63% | 12 | 71.43% | 4 | -42.86% |
| Sep 30, 2023 | 31 | -3.13% | 15,860,510 | -0.89% | 57 | 1.70% | 7 | 40.00% | 7 | 16.67% |
| Jun 30, 2023 | 32 | - | 16,002,286 | -0.43% | 58 | 1.70% | 5 | -50.00% | 6 | 100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 739.56K | 1.68% | - |
| Fidelity Extended Market Index | 186.93K | 0.43% | 58.92K |
| Vanguard Institutional Extnd Mkt Idx Tr | 160.02K | 0.36% | - |
| Bridgeway Ultra-Small Company Market | 71.08K | 0.16% | - |
| iShares Micro-Cap ETF | 66.92K | 0.15% | - |
| Fidelity Total Market Index | 64.21K | 0.15% | 53.14K |
| Fidelity Series Total Market Index | 43.22K | 0.10% | 27.84K |
| NT Ext Equity Mkt Idx Fd - L | 30.97K | 0.07% | - |
| Northern Trust Extended Eq Market Idx | 30.97K | 0.07% | - |
| Spartan Extended Market Index Pool E | 18.56K | 0.04% | 18.56K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 02, 2024 | GILEAD SCIENCES, INC. | - | Buy | $388.25 |
| Apr 02, 2024 | GILEAD SCIENCES, INC. | - | Buy | $368.79K |
| Feb 08, 2024 | Atlas Venture Fund XI, L.P. | - | Sell | $469.12 |
| Feb 08, 2024 | Atlas Venture Fund XI, L.P. | - | Sell | $170.88 |
| Jan 11, 2024 | Atlas Venture Fund XI, L.P. | - | Sell | $1.36K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | 2 | - |
| 2024 Q1 | - | 6 |
| 2023 Q3 | - | - |
XLO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools